Ovarian Cancer Clinical Trial Award
The OCRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of ovarian cancer. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) to demonstrate the feasibility or inform the design of more advanced trials through large-scale trials to determine efficacy in relevant patient populations.
Award Range
Not specified - Not specified
Total Program Funding
$6,400,000
Number of Awards
2
Matching Requirement
No
Eligible Applicants
Additional Requirements
Eligible Applicants II.C.1.a. Organization: Extramural and Intramural organizations are eligible to apply, including foreign or domestic institutions, for-profit and non-profit organizations, and public entities. DOD FY24 Ovarian Cancer Clinical Trial Award 7 Extramural Organization: An eligible non-Department of Defense (DOD) organization. Examples of extramural organizations include academic institutions, biotechnology companies, foundations, federal government organizations other than the DOD (i.e., intragovernmental organizations), and research institutes. Intramural DOD Organization: Refers specifically to DOD organizations including DOD laboratories, DOD military treatment facilities, and/or DOD activities embedded within a civilian medical center. Awards are made to eligible organizations, not to individuals. Refer to the General Application Instructions, Appendix 1, for additional recipient qualification requirements.
Geographic Eligibility
All
Next Deadline
June 3, 2024
Letter of Intent
Application Opens
March 26, 2024
Application Closes
August 6, 2024
Subscribe to view contact details